chr17-79115654-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001350451.2(RBFOX3):​c.62A>G​(p.Glu21Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000099 in 1,009,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E21K) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 24)
Exomes 𝑓: 9.9e-7 ( 0 hom. )

Consequence

RBFOX3
NM_001350451.2 missense

Scores

2
6
7

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.46

Publications

0 publications found
Variant links:
Genes affected
RBFOX3 (HGNC:27097): (RNA binding fox-1 homolog 3) This gene encodes a member of the RNA-binding FOX protein family which is involved in the regulation of alternative splicing of pre-mRNA. The protein has an N-terminal proline-rich region, an RNA recognition motif (RRM) domain, and a C-terminal alanine-rich region. This gene produces the neuronal nuclei (NeuN) antigen that has been widely used as a marker for post-mitotic neurons. This gene has its highest expression in the central nervous system and plays a prominent role in neural tissue development and regulation of adult brain function. Mutations in this gene have been associated with numerous neurological disorders. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2017]
RBFOX3 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3253514).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001350451.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RBFOX3
NM_001350451.2
MANE Select
c.62A>Gp.Glu21Gly
missense
Exon 5 of 15NP_001337380.1A0A8I5KWJ3
RBFOX3
NM_001385804.1
c.62A>Gp.Glu21Gly
missense
Exon 5 of 15NP_001372733.1
RBFOX3
NM_001385805.1
c.62A>Gp.Glu21Gly
missense
Exon 6 of 16NP_001372734.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RBFOX3
ENST00000693108.1
MANE Select
c.62A>Gp.Glu21Gly
missense
Exon 5 of 15ENSP00000510395.1A0A8I5KWJ3
RBFOX3
ENST00000857749.1
c.62A>Gp.Glu21Gly
missense
Exon 5 of 15ENSP00000527808.1
RBFOX3
ENST00000583458.5
TSL:5
c.62A>Gp.Glu21Gly
missense
Exon 4 of 14ENSP00000464186.1J3QRF4

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD4 exome
AF:
9.90e-7
AC:
1
AN:
1009856
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
488568
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
20780
American (AMR)
AF:
0.00
AC:
0
AN:
14810
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12288
East Asian (EAS)
AF:
0.00
AC:
0
AN:
17306
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
17536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3880
European-Non Finnish (NFE)
AF:
0.00000120
AC:
1
AN:
832288
Other (OTH)
AF:
0.00
AC:
0
AN:
38728
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
24

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.021
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
26
DANN
Uncertain
0.98
DEOGEN2
Benign
0.18
T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Benign
0.064
D
MetaRNN
Benign
0.33
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.5
PrimateAI
Uncertain
0.75
T
Sift4G
Benign
0.061
T
Polyphen
0.99
D
Vest4
0.45
MutPred
0.19
Loss of stability (P = 0.0385)
MVP
0.45
ClinPred
0.94
D
GERP RS
4.3
PromoterAI
-0.019
Neutral
Varity_R
0.53
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1167103679; hg19: chr17-77111736; API